On April 15th 2012, the Financial Times reported that Sanofi’s drug Multaq lost reimbursement in France and faced new restrictions in other countries. Multaq (Dronedarone) is a drug manufactured by...
(PRWeb April 26, 2012)
Read the full story at http://www.prweb.com/releases/2012/4/prweb9442910.htm